NextGen Healthcare (NXGN) Stock Forecast, Price & News

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for NextGen Healthcare in the last twelve months. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" NXGN shares.
View NXGN analyst ratings or view top-rated stocks.

4 brokers have issued 12-month target prices for NextGen Healthcare's stock. Their NXGN share price forecasts range from $17.00 to $25.00. On average, they expect the company's share price to reach $21.20 in the next year. This suggests a possible upside of 30.4% from the stock's current price.
View analysts price targets for NXGN or view top-rated stocks among Wall Street analysts.

NextGen Healthcare's stock was trading at $18.78 at the start of the year. Since then, NXGN shares have decreased by 13.4% and is now trading at $16.26.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, July 25th 2023.
View our NXGN earnings forecast.

NextGen Healthcare, Inc. (NASDAQ:NXGN) announced its earnings results on Tuesday, May, 16th. The company reported $0.23 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.18 by $0.05. The business earned $178.55 million during the quarter, compared to analysts' expectations of $170.61 million. NextGen Healthcare had a negative net margin of 0.41% and a positive trailing twelve-month return on equity of 8.51%.

ETFs with the largest weight of NextGen Healthcare (NASDAQ:NXGN) stock in their portfolio include Global X Telemedicine & Digital Health ETF (EDOC), Fidelity Digital Health ETF (FDHT), AdvisorShares Alpha DNA Equity Sentiment ETF (SENT), Invesco S&P SmallCap Health Care ETF (PSCH), Vanguard U.S. Minimum Volatility ETF (VFMV), ETC 6 Meridian Low Beta Equity Strategy ETF (SIXL), Invesco S&P SmallCap 600 Pure Growth ETF (RZG) and Royce Quant Small-Cap Quality Value ETF (SQLV).

NextGen Healthcare updated its FY 2024 earnings guidance on Friday, May, 26th. The company provided EPS guidance of $1.04-$1.11 for the period, compared to the consensus EPS estimate of $1.10. The company issued revenue guidance of $712.00 million-$722.00 million, compared to the consensus revenue estimate of $709.32 million.

248 employees have rated NextGen Healthcare Chief Executive Officer Rusty Frantz on Glassdoor.com. Rusty Frantz has an approval rating of 72% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other NextGen Healthcare investors own include Altria Group (MO), Verizon Communications (VZ), Exxon Mobil (XOM), Best Buy (BBY), Enbridge (ENB), Enterprise Products Partners (EPD), Huntington Bancshares (HBAN), Netflix (NFLX), Tapestry (TPR) and Twitter (TWTR).

NextGen Healthcare trades on the NASDAQ under the ticker symbol "NXGN."

NextGen Healthcare's stock is owned by many different retail and institutional investors. Top institutional shareholders include BlackRock Inc. (14.26%), Dimensional Fund Advisors LP (3.66%), State Street Corp (2.99%), William Blair Investment Management LLC (2.34%), Alyeska Investment Group L.P. (1.76%) and Geode Capital Management LLC (1.68%). Insiders that own company stock include Craig A Barbarosh, David A Metcalfe, David Ahmadzai, David William Sides, Donna Cullen Greene, George H Bristol, James Robert Jr Arnold, John R Frantz, Lance Rosenzweig, Mitchell Waters, Sean Brynjelsen and Srinivas S Velamoor.
View institutional ownership trends.

Shares of NXGN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of NXGN stock can currently be purchased for approximately $16.26.

NextGen Healthcare (NASDAQ:NXGN) has a market capitalization of $1.07 billion and generates $653.17 million in revenue each year. The company earns $-2,650,000.00 in net income (profit) each year or ($0.04) on an earnings per share basis.

The company employs 2,783 workers across the globe.

NextGen Healthcare's mailing address is 18111 Von Karman Avenue Suite 800, Irvine CA, 92612. The official website for the company is www.nextgen.com. The company can be reached via phone at (949) 255-2600, via email at ir@nextgen.com, or via fax at 949-255-2605.